Description

• General description: High purity Fmoc-protected amino acid for research and process production of peptides, with very low levels of dipeptide, free-amino acids and acetic acid impurities. Standard building block for introduction of aspartic acid amino-acid residues by Fmoc SPPS Associated Protocols and Technical ArticlesCleavage and Deprotection Protocols for Fmoc SPPS
• Application: Silybin liver research: Silybin A and B, as part of the silymarin complex, are extensively studied for their hepatoprotective properties. They play a crucial role in liver health by mitigating oxidative stress and enhancing regenerative processes in hepatic tissue (Cai et al., 2024).Silybin pharmacological research: The pharmacological effects of silybin, particularly its roles in inhibiting inflammation and modulating drug metabolizing enzymes, make it a valuable compound in therapeutic research, particularly for its benefits in hepatology and oncology (Hammad et al., 2024).
• Linkage: Replaces: 04-12-1013
• Analysis Note: Colour (visual): white to off whiteAppearance of substance (visual): powderColour index (0,5 M in DMF): ≤ 150 HazenIdentity (IR): passes testEnantiomeric purity: ≥ 99.8 % (a/a)Purity (HPLC): ≥ 99.0 % (a/a)Fmoc-ß-Ala-OH (HPLC): ≤ 0.1 % (a/a)Fmoc-ß-Ala-Asp (OtBu)-OH (HPLC): ≤ 0.1 % (a/a)Fmoc-Asp(OtBu)-Asp(OtBu)-OH (HPLC): ≤ 0.1 % (a/a)Fmoc-Asp-OH (HPLC): ≤ 0.1 % (a/a)Assay free amino acid (GC): ≤ 0.2 %Purity (TLC(011A)): ≥ 98 %Purity (TLC(0811)): ≥ 98 %Solubility (25 mmole in 50 ml DMF): clearly solubleAssay (acidimetric): ≥ 98.0 %Water (K. F.): ≤ 2.0 %Ethyl acetate (HS-GC): ≤ 0.5 %Acetate (IC): ≤ 0.02 %To see the solvent systems used for TLC of Novabiochem® products please click here.
• Legal Information: Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany